Jon Wigginton
2018
In 2018, Jon Wigginton earned a total compensation of $2M as Senior Vice President, Clinical Development and Chief Medical Officer at MacroGenics, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $173,328 |
|---|---|
| Option Awards | $1,334,529 |
| Salary | $460,000 |
| Other | $8,250 |
| Total | $1,976,107 |
Wigginton received $1.3M in option awards, accounting for 68% of the total pay in 2018.
Wigginton also received $173.3K in non-equity incentive plan, $460K in salary and $8.3K in other compensation.
Rankings
In 2018, Jon Wigginton's compensation ranked 5,815th out of 14,244 executives tracked by ExecPay. In other words, Wigginton earned more than 59.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,815 out of 14,244 | 59th |
Division Manufacturing | 2,203 out of 5,759 | 62nd |
Major group Chemicals And Allied Products | 816 out of 2,122 | 62nd |
Industry group Drugs | 682 out of 1,811 | 62nd |
Industry Pharmaceutical Preparations | 529 out of 1,385 | 62nd |
Source: SEC filing on April 2, 2020.
Wigginton's colleagues
We found four more compensation records of executives who worked with Jon Wigginton at MacroGenics in 2018.